Previously, we reported a significant up-regulation of PD-L1 expression on the tumor cells and an increased stromal density of CD8 + tumor infiltrative lymphocytes (TILs) in paired clinical samples before and after cCRT20. This evidence concerns the gene CD274 and neoplasm.